# Comprehensive analysis of anoikis-related gene signature in ulcerative colitis using machine learning algorithms

**Authors:** Peng Liu, Chunyan Sun, Xiaojuan Wang, Bing Han, Yuhao Sun, Yanbing Liu, Xin Zeng

PMC · DOI: 10.3389/fmed.2025.1498864 · Frontiers in Medicine · 2025-03-06

## TL;DR

This study identifies five key genes related to anoikis that are linked to immune cell infiltration in ulcerative colitis, offering potential biomarkers for diagnosis and treatment.

## Contribution

The study introduces a novel analysis of anoikis-related genes in ulcerative colitis using machine learning to identify key biomarkers and their immune cell correlations.

## Key findings

- Five key anoikis-DEGs (PDK4, CEACAM6, CFB, CX3CL1, HLA-DMA) were identified with high diagnostic accuracy for UC.
- CEACAM6, CFB, CX3CL1, and HLA-DMA showed positive associations with immune cell infiltration in UC.
- Unsupervised clustering categorized UC patients into two distinct subgroups with unique gene expression profiles.

## Abstract

Ulcerative colitis (UC) is a chronic inflammatory bowel disease with an idiopathic origin, characterized by persistent mucosal inflammation. Anoikis is a programmed cell death mechanism activated during carcinogenesis to eliminate undetected isolated cells from the extracellular matrix. Although existing evidence indicates that anoikis contributes to the modulation of immune response, the involvement of anoikis-related genes (ARGs) in UC pathogenesis and their interaction with infiltrating immune cells has not been thoroughly explored. The GSE75214, GSE92415, and GSE16879 datasets were acquired and integrated from the GEO database. Additionally, 58 ARGs were identified through the GSEA database. Key anoikis-DEGs in UC were identified using three machine learning algorithms, including least absolute shrinkage and selection operator (LASSO) Cox regression, random forest (RF), and support vector machine (SVM). Receiver operating characteristic (ROC) analysis was utilized to evaluate the diagnostic accuracy of each gene. Subsequently, Single sample GSEA (ssGSEA) was executed to explore the relationships within immune cell infiltration, UC subtypes, and key anoikis-DEGs. Besides, unsupervised cluster analysis was conducted to categorize the UC samples into distinct subgroups, followed by comparing subtype differences. Finally, the upstream regulatory network was constructed and visualized. A comprehensive analysis of the involvement of ARGs in UC was performed, revealing their expression profile, correlation with infiltrating immune cells, and enrichment analyses. We identified five key anoikis-DEGs (PDK4, CEACAM6, CFB, CX3CL1, and HLA-DMA) and demonstrated their high diagnostic accuracy for UC. Moreover, CEACAM6, CFB, CX3CL1, and HLA-DMA exhibited positive associations with infiltrating immune cells in UC, whereas PDK4 displayed a negative correlation with all immune cells. Unsupervised cluster analysis enabled the classification of UC patients into two clusters, both of which exhibited distinct gene expression profiles and immune signaling pathways. Further, based upon the upstream regulatory network, TP53, RARB, RXRB, and CTCF potentially exerted regulatory functions. Our analysis identified five key anoikis-DEGs as characteristic biomarkers of UC. These genes were strongly associated with the infiltration of both innate and adaptive immune cells, as well as immune pathways. This study highlights the role of anoikis genes in UC pathophysiology and offers valuable insights for further elucidating UC pathogenesis and individualized therapy.

## Linked entities

- **Genes:** PDK4 (pyruvate dehydrogenase kinase 4) [NCBI Gene 5166], CEACAM6 (CEA cell adhesion molecule 6) [NCBI Gene 4680], CFB (complement factor B) [NCBI Gene 629], CX3CL1 (C-X3-C motif chemokine ligand 1) [NCBI Gene 6376], HLA-DMA (major histocompatibility complex, class II, DM alpha) [NCBI Gene 3108], TP53 (tumor protein p53) [NCBI Gene 7157], RARB (retinoic acid receptor beta) [NCBI Gene 5915], RXRB (retinoid X receptor beta) [NCBI Gene 6257], CTCF (CCCTC-binding factor) [NCBI Gene 10664]
- **Diseases:** ulcerative colitis (MONDO:0005101)

## Full-text entities

- **Genes:** CFB (complement factor B) [NCBI Gene 629] {aka AHUS4, ARMD14, BF, BFD, CFAB, CFBD}, RXRB (retinoid X receptor beta) [NCBI Gene 6257] {aka DAUDI6, H-2RIIBP, NR2B2, RCoR-1, RXR-beta, RXRbeta}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, RARB (retinoic acid receptor beta) [NCBI Gene 5915] {aka HAP, MCOPS12, NR1B2, RARbeta, RARbeta1, RRB2}, CX3CL1 (C-X3-C motif chemokine ligand 1) [NCBI Gene 6376] {aka ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT}, CEACAM6 (CEA cell adhesion molecule 6) [NCBI Gene 4680] {aka CD66c, CEAL, NCA, NCA-50/90}, PDK4 (pyruvate dehydrogenase kinase 4) [NCBI Gene 5166], CTCF (CCCTC-binding factor) [NCBI Gene 10664] {aka CFAP108, FAP108, MRD21}, HLA-DMA (major histocompatibility complex, class II, DM alpha) [NCBI Gene 3108] {aka D6S222E, DMA, HLADM, RING6}
- **Diseases:** inflammatory bowel disease (MESH:D015212), UC (MESH:D003093), mucosal inflammation (MESH:D007249), carcinogenesis (MESH:D063646)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11922952/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11922952/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC11922952/full.md

---
Source: https://tomesphere.com/paper/PMC11922952